RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression
Clinical trial NCT05940896 · RECRUITING
Trial details
- NCT number
- NCT05940896
- Sponsor
- RemeGen Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-29
- Primary completion
- 2024-11-16
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.